Crossmark Global Holdings’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-23,910
Closed -$183K 1444
2020
Q3
$183K Hold
23,910
0.01% 1248
2020
Q2
$145K Hold
23,910
﹤0.01% 1283
2020
Q1
$84K Sell
23,910
-10
-0% -$85 ﹤0.01% 1196
2019
Q4
$253K Buy
+23,920
New +$212K 0.01% 1216
2019
Q1
Sell
-11,322
Closed -$28K 1417
2018
Q4
$28K Sell
11,322
-4,040
-26% -$14.5K ﹤0.01% 1381
2018
Q3
$69K Buy
15,362
+310
+2% +$2.26K ﹤0.01% 1584
2018
Q2
$180K Buy
15,052
+3,980
+36% +$53.3K ﹤0.01% 1545
2018
Q1
$171K Sell
11,072
-452
-4% -$7.55K ﹤0.01% 1525
2017
Q4
$188K Buy
11,524
+1,502
+15% +$29K ﹤0.01% 1596
2017
Q3
$229K Buy
+10,022
New +$214K 0.01% 1491
2016
Q3
$229K Buy
+10,022
New +$266K 0.01% 1491

Other funds holding DBD

Crossmark Global Holdings's DBD Position: Q4 2020 in Review

Crossmark Global Holdings sold out of Diebold Nixdorf Incorporated (DBD) in Q4 2020, closing a stake of 23,910 shares — an estimated $183K sold.

Crossmark Global Holdings first reported a position in DBD in Q3 2016 and held it in 11 quarters. The position peaked at $253K in Q4 2019. 187 funds tracked by Wall St. Rank hold DBD as of Q4 2020.

  • Crossmark Global Holdings reported no remaining Diebold Nixdorf Incorporated position as of Q4 2020 after selling out during the quarter.
  • Crossmark Global Holdings sold 23,910 Diebold Nixdorf Incorporated shares in Q4 2020, an estimated $183K.
  • Crossmark Global Holdings first reported a position in Diebold Nixdorf Incorporated in Q3 2016 and held it in 11 quarters.
  • Crossmark Global Holdings's Diebold Nixdorf Incorporated position peaked at $253K in Q4 2019.
  • 187 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q4 2020.

Based on Crossmark Global Holdings's 13F filing for Q4 2020, filed 14 Jan 2021.